ESC 365 - EMPEROR-Pooled: effect of empagliflozin on serious adverse renal outcomes in chronic heart failure – a prospective alpha-protected, Individual patient-level pooled analysis

ESC Premium Access

EMPEROR-Pooled: effect of empagliflozin on serious adverse renal outcomes in chronic heart failure – a prospective alpha-protected, Individual patient-level pooled analysis

Session: Hot Line - EMPEROR-Preserved / EMPEROR-Pooled

Topic: Pharmacotherapy

Speaker: Professor M. Packer (Dallas, US)

Event: ESC Congress 2021 - The Digital Experience

Congress Presentation

Add to my library

About the speaker

Professor Milton Packer

Baylor University Medical Center, Dallas (United States of America)

59 presentations

17 followers

4 more presentations in this session

EMPEROR-Preserved: effect of empagliflozin on cardiovascular death and heart failure hospitalisations in patients with heart failure with a preserved ejection fraction, with and without diabetes

Speaker: Professor S. Anker (Berlin, DE)

EMPEROR-Preserved - Discussant review.

Speaker: Professor F. Ruschitzka (Zurich, CH)

EMPEROR-Pooled - Discussant review.

Speaker: Professor R. De Boer (Rotterdam, NL)

EMPEROR-Preserved / EMPEROR-Pooled - Panel discussion.

Access the full session

Hot Line - EMPEROR-Preserved / EMPEROR-Pooled

Speakers: Professor M. Packer, Professor S. Anker, Professor F. Ruschitzka, Professor R. De Boer

About the event

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources